APA

Dovlatova N. L., Jakubowski J. A., Sugidachi A. & Heptinstall S. (20080813). The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function. : Journal of thrombosis and haemostasis : JTH.

Chicago

Dovlatova N L, Jakubowski J A, Sugidachi A and Heptinstall S. 20080813. The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function. : Journal of thrombosis and haemostasis : JTH.

Harvard

Dovlatova N. L., Jakubowski J. A., Sugidachi A. and Heptinstall S. (20080813). The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function. : Journal of thrombosis and haemostasis : JTH.

MLA

Dovlatova N L, Jakubowski J A, Sugidachi A and Heptinstall S. The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function. : Journal of thrombosis and haemostasis : JTH. 20080813.